Mobile Menu - OpenMobile Menu - Closed

Hearing on “Combating the Opioid Epidemic: Examining Concerns About Distribution and Diversion,” Subcommittee on Oversight and Investigations (May 8, 2018)

Date: 
Tuesday, May 8, 2018 - 10:00am
Location: 
2123 Rayburn House Office Building

The Subcommittee on Oversight and Investigations held a hearing on Tuesday, May 8, 2018, at 10:00 a.m. in 2123 Rayburn House Office Building. The hearing is entitled “Combating the Opioid Epidemic: Examining Concerns About Distribution and Diversion.”  

 

Livestream

 

Key Documents

Memorandum from Ranking Member Pallone to the Subcommittee on Oversight and Investigations

Opening Statement of Ranking Member Pallone as prepared for delivery

Opening Statement of Subcommittee Ranking Member DeGette as prepared for delivery

Preliminary Transcript

 

Witnesses

Mr. George Barrett
Executive Chairman of the Board
Cardinal Health Inc.

Testimony


Mr. Steven Collis
Chairman, President, and CEO
AmerisourceBergen Corporation

Testimony


Mr. John Hammergren
Chairman, President, and CEO
McKesson Corporation

Testimony


Dr. Joseph Mastandrea
Chairman of the Board
Miami-Luken, Inc.

Testimony


Mr. J. Christopher Smith
Former President and CEO
H.D. Smith Wholesale Drug Company

Testimony

Issues: